Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: BOD..regardless is ultimately responsible!

After re-reading some of the official PTSC press releases, it appears that the company set the tone for shareholder expectations.

The following are direct quotes form David Pohl, chairman and CEO of Patriot Scientific

11-12-2006

"Increased value for Patriot Scientific shareholders is our fundamental driver," Pohl continued. "While the very busy Alliacense team negotiates with more and more global manufacturers to become licensees of our jointly owned patent portfolio, the Patriot management and board are pursuing the other prong of our two-fold strategy by engaging in ongoing negotiations for a potential joint venture to enhance our Ignite(TM) chip as well as engaging in communications with another technology company whose attractive potential may lead to an investment or acquisition by Patriot."
http://patriotscientific.com/index.php?option=com_content&task=view&id=105&Itemid=29

1-18-2007

"We are delighted that the strength of our patent portfolio continues to be validated by the 12 licenses that have been signed thus far with major electronics companies, 10 of them during calendar year 2006," said Pohl. "Our outlook remains positive for continued revenue based on further progress in licensing more of over 400 companies worldwide that have been notified they are candidates."

Pohl also noted that Patriot Scientific is continuing to actively evaluate sources and opportunities to create additional recurring revenue through possible joint ventures or acquisitions, all with the goal of increasing shareholder value. http://patriotscientific.com/index.php?option=com_content&task=view&id=107&Itemid=29

2-8-2007

"We will continue to seek and evaluate opportunities to diversify our revenue stream by developing and marketing new technologies, entering into joint ventures or by acquiring other companies and technologies," Pohl stated, "always pointed toward the goal of increasing the financial position and strength of the company and providing value to our shareholders."
http://patriotscientific.com/index.php?option=com_content&task=view&id=108&Itemid=29

Share
New Message
Please login to post a reply